OPKO Health Inc (OPK)

3.88 +0.26  +7.18% NASDAQ Jul 28, 16:59 USD
View Full Chart
Price Chart
View All OPK News


View All Events


Date Type Description
07/29/2021 Earnings Results Q2 2021 Earnings Results
07/29/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
06/24/2021 10:00 EST AGM 2020 Annual General Meeting
04/28/2021 Earnings Results Q1 2021 Earnings Results
04/28/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
02/18/2021 Earnings Results Q4 2020 Earnings Results
02/18/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
10/29/2020 Earnings Results Q3 2020 Earnings Results
10/29/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
07/30/2020 16:45 EST Earnings Calls Q2 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Opko Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a specialty active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.
  • URL: https://www.opko.com
  • Investor Relations URL: https://www.opko.com/investors
  • HQ State/Province: Florida
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Jul. 29, 2021
  • Last Earnings Release: Apr. 28, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
F000014EGR ST Healthcare Innovations 8 F CA 9.54%
F0000155EV ST Healthcare Innovations 9 F RE 6.56%
F0000173CB FT Biotechnology 53 CA 3.71%
FHMTWX FT Biotechnology 51 RE 3.07%
PBE Invesco Dynamic Biotech & Genome ETF 2.77%
F000016JRV FT Biotechnology 52 F CA 2.64%
F000015MKL FT Biotechnology 50 F RE 2.48%
GERM ETFMG Treatments Testing and Adv ETF 1.25%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.